Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Strikes Deals with Schering-Plough, Pfizer; Licenses Patented Tech

Premium

PALO ALTO, Calif.--Incyte Pharmaceuticals announced a broad genomic data collaboration that provides Schering-Plough with access to Incyte's microarray technology and databases. Incyte will provide Plough with data from custom and prefabricated DNA microarrays in exchange for technology access and per-array fees. The multiyear collaboration also provides Plough with access to Incyte's LifeSeq gene sequence and expression database and the LifeSeq FL database of full-length genes. Financial terms of the agreement were not disclosed.

Separately, expanding upon an existing relationship, Incyte granted Pfizer a license to its LifeTools bioinformatics software and LifeArray microarray data analysis and management software.

Incyte also announced that it has been granted an exclusive license to what it called a "pioneering gene expression analysis technology" from the Montefiore Medical Center. The technology uses a defined hybridization array to analyze gene expressions useful in diagnosing disease. The method can also be used to evaluate potential risk for disease and monitor the effects of drugs on gene expression, according to Incyte.

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.